PTEN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
PTEN is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some constructive longer-term analyst support and positive industry commentary, but the current technical picture is weak, insider selling is elevated, and there is no proprietary buy signal. If you are unwilling to wait, this is still not the cleanest entry; I would not call it a good buy today.
The stock is trading pre-market at 11.39, up 0.80%, but the trend remains fragile. MACD histogram is -0.153 and still negatively expanding, which points to ongoing downside momentum. RSI_6 at 25.771 suggests the stock is near oversold levels, but not yet showing a confirmed reversal. Moving averages are converging, which usually signals a potential inflection, but price is still below the pivot at 12.179 and below R1 at 12.869. Immediate support sits near 11.489 and then 11.064, so the stock is hovering close to support rather than in a confirmed uptrend.
Recent analyst action has been favorable, with multiple price target raises and several positive or overweight ratings. Barclays now sees the sector setup as very strong, citing a multi-year upstream spending cycle and higher oil prices. Susquehanna and BofA also raised targets, and Piper Sandler noted Q2 EBITDA estimates were revised higher to $220M, above consensus. News also shows Sourcerock Group increased its stake materially, which is a positive institutional signal. The Q1 revenue base was solid at $1.1B, and adjusted EBITDA of $205M indicates the business is still generating meaningful operating cash flow.
Insiders are selling heavily, with selling up 359.61% over the last month, which is a meaningful negative. The stock also reacted poorly to good company commentary, suggesting the market is still cautious. Analyst ratings are mixed overall because several firms remain Neutral/Equal Weight despite higher targets. The latest quarter included a $25M net loss, so profitability remains uneven. The stock trend model also points to weak near-term performance expectations, with a negative projected move over the next week and month.
Latest quarter: Q1 2026. Patterson-UTI reported $1.1 billion in revenue and $205 million in adjusted EBITDA, which is a solid operating result and supports the case that the core business remains sizable and resilient. Management also lifted Q2 EBITDA expectations to $220M, above the prior $206M consensus, which is a clear growth signal. The main weakness is that the company still posted a $25 million net loss, so earnings quality is not yet fully converted into bottom-line profitability.
Wall Street is cautiously constructive overall. Recent price target revisions have moved higher across the board: Piper Sandler to $13, Susquehanna to $14, BofA to $13.50, Barclays to $15, Stifel to $14, RBC to $14, and Capital One to $12. The pros case is improving U.S. land drilling/frac activity, tightening frac capacity, and an expected earnings revision cycle. The con case is that several firms still keep Neutral or only modestly positive ratings, which suggests the upside is recognized but not seen as immediate or clean. Overall, analysts are more positive on the medium-term setup than the current chart confirms.
